GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Yifeng Pharmacy Chain Co 603939.SS · CNY

Consumer Staples · Shanghai · 🇨🇳 China

Compare

25.32

-6.46%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥24.43bn

FY2016FY2025

Net income

CN¥1.68bn

FY2016FY2025

Free cash flow

CN¥3.04bn

FY2016FY2025

Shareholders' equity

CN¥11.63bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥24.43bnCN¥24.06bnCN¥22.59bnCN¥19.89bnCN¥15.33bnCN¥13.14bnCN¥10.28bnCN¥6.91bnCN¥4.81bnCN¥3.73bn
Gross profitCN¥9.62bnCN¥9.57bnCN¥8.56bnCN¥7.80bnCN¥6.14bnCN¥4.96bnCN¥3.99bnCN¥2.73bnCN¥1.92bnCN¥1.47bn
Research and developmentCN¥27.9mCN¥33.9mCN¥33.5mCN¥25.3mCN¥15.6mCN¥8.3mCN¥5.4mCN¥3.2mCN¥2.4mCN¥14.8m
Operating incomeCN¥2.51bnCN¥2.20bnCN¥2.05bnCN¥1.89bnCN¥1.34bnCN¥1.13bnCN¥815.5mCN¥517.6mCN¥427.2mCN¥296.2m
Net incomeCN¥1.68bnCN¥1.53bnCN¥1.41bnCN¥1.26bnCN¥887.9mCN¥743.5mCN¥543.8mCN¥416.4mCN¥313.5mCN¥223.9m
Diluted earnings per share1.381.081.401.250.740.760.790.620.470.35

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥27.45bnCN¥27.97bnCN¥24.14bnCN¥21.04bnCN¥17.05bnCN¥12.95bnCN¥9.18bnCN¥7.87bnCN¥4.78bnCN¥4.22bn
Cash and short-term investments—CN¥7.99bnCN¥5.20bnCN¥4.16bnCN¥3.07bnCN¥4.10bnCN¥1.62bnCN¥1.30bnCN¥787.5mCN¥346.6m
Total liabilitiesCN¥15.07bnCN¥16.58bnCN¥13.69bnCN¥11.92bnCN¥9.19bnCN¥7.17bnCN¥4.47bnCN¥3.70bnCN¥1.60bnCN¥1.25bn
DebtCN¥1.65bnCN¥3.94bnCN¥2.34bnCN¥3.46bnCN¥3.33bnCN¥2.42bnCN¥775.4mCN¥789.0mCN¥920.2mCN¥745.0m
Shareholders' equityCN¥11.63bnCN¥10.73bnCN¥9.80bnCN¥8.56bnCN¥7.48bnCN¥5.47bnCN¥4.51bnCN¥4.06bnCN¥3.17bnCN¥2.96bn
Shares outstanding1,212m1,409m1,008m1,006m1,194m980m685m676m661m633m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥3.36bnCN¥4.22bnCN¥4.66bnCN¥3.92bnCN¥2.15bnCN¥1.34bnCN¥963.2mCN¥510.7mCN¥317.2mCN¥139.9m
Capital spending−CN¥322.9m−CN¥682.7m−CN¥739.9m−CN¥587.5m−CN¥827.5m−CN¥582.8m−CN¥454.0m−CN¥233.7m−CN¥206.7m−CN¥254.9m
Free cash flowCN¥3.04bnCN¥3.54bnCN¥3.92bnCN¥3.33bnCN¥1.32bnCN¥752.9mCN¥509.2mCN¥277.0mCN¥110.5m−CN¥114.9m
Dividends paid−CN¥849.3m−CN¥846.5m−CN¥288.7m−CN¥215.6m−CN¥165.9m−CN¥113.7m−CN¥113.0m−CN¥183.6m−CN¥54.1m−CN¥54.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥6.04bnCN¥6.09bnCN¥7.15bnCN¥5.56bnCN¥5.71bnCN¥6.01bnCN¥6.84bnCN¥5.46bn
Gross profitCN¥2.45bnCN¥2.44bnCN¥2.63bnCN¥2.24bnCN¥2.31bnCN¥2.38bnCN¥2.62bnCN¥2.28bn
Operating incomeCN¥732.3mCN¥741.5mCN¥694.0mCN¥479.0mCN¥621.8mCN¥650.5mCN¥618.3mCN¥451.6m
Net incomeCN¥464.2mCN¥499.5mCN¥453.9mCN¥344.5mCN¥430.6mCN¥449.5mCN¥418.1mCN¥312.8m
Diluted earnings per share0.380.410.370.280.360.370.300.22
Cash from operations———CN¥641.0mCN¥455.0mCN¥1.11bnCN¥961.0m−CN¥5.28bn
Capital spending−CN¥52.0m−CN¥13.0m−CN¥214.0m−CN¥44.0m−CN¥9.0m−CN¥53.0m−CN¥362.0m−CN¥110.0m
Free cash flow———CN¥597.0mCN¥446.0mCN¥1.06bnCN¥599.0m−CN¥5.39bn
Total assetsCN¥25.83bnCN¥26.84bnCN¥27.45bnCN¥26.07bnCN¥26.32bnCN¥27.79bnCN¥27.97bnCN¥27.21bn
Cash and short-term investments———CN¥8.11bnCN¥7.91bnCN¥8.50bnCN¥7.99bnCN¥8.06bn
DebtCN¥1.67bnCN¥1.66bnCN¥1.65bnCN¥6.84bnCN¥1.66bnCN¥1.64bnCN¥1.63bnCN¥1.68bn
Shareholders' equityCN¥12.12bnCN¥12.13bnCN¥11.63bnCN¥10.96bnCN¥11.15bnCN¥11.19bnCN¥10.73bnCN¥10.03bn

Financial ratios

Data as of 22 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin39.4%39.8%37.9%39.2%40.1%37.7%
Operating margin10.3%9.2%9.1%9.5%8.7%8.6%
Net margin6.9%6.4%6.3%6.3%5.8%5.7%
Return on equity14.4%14.3%14.4%14.7%11.9%13.6%
Return on assets6.1%5.5%5.8%6.0%5.2%5.7%
Free cash flow yield13.7%15.7%24.1%20.2%11.2%8.8%
Revenue growth1.5%6.5%13.6%29.8%16.6%27.9%
Earnings growth9.8%8.3%11.9%42.1%19.4%36.7%
Current ratio1.43x1.26x1.08x1.10x1.17x1.57x
Debt to equity0.14x0.15x0.01x0.04x0.17x0.43x
Equity ratio42.4%38.3%40.6%40.7%43.9%42.2%
Interest coverage15.08x8.94x12.80x10.59x7.92x5.67x
R&D as a share of sales0.1%0.1%0.1%0.1%0.1%0.1%
Buybacks as a share of market value14.0%-39.8%-0.2%15.8%-21.8%-43.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.1%13.2%24.0%
Operating income10.1%17.3%26.9%
Net income10.0%17.7%25.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin39.6%39.1%39.1%39.1%
Operating margin9.7%9.5%9.3%9.1%
Net margin6.6%6.5%6.3%6.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.722.323.830.344.154.530.222.131.427.4
Price to sales1.11.41.51.92.63.11.61.32.01.6

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 25 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.400.700.750.2380.1790.1370.0980.098
  • 6-for-5 split · 7 Jun 2024
  • 7-for-5 split · 7 Jun 2023
  • 13-for-10 split · 7 Jun 2021
  • 7-for-5 split · 18 May 2020
  • 2-for-1 split · 6 Nov 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.